Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus. (Q40466985)

20 September 2017

title

Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus. (English)

1 reference

20 September 2017

main subject

classical swine fever

1 reference

classical swine fever virus

inferred from title

object named as

classical swine fever virus

1 reference

Siguo Liu

1

1 reference

20 September 2017

Xinglong Yu

2

1 reference

20 September 2017

Chunlai Wang

3

1 reference

20 September 2017

Jianmin Wu

4

1 reference

20 September 2017

Xiangang Kong

5

1 reference

20 September 2017

Changchun Tu

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

5 July 2006

1 reference

20 September 2017

number of pages

6

1 reference

inferred from page(s)

published in

Vaccine

1 reference

20 September 2017

volume

24

1 reference

20 September 2017

issue

49-50

1 reference

20 September 2017

page(s)

7175-7180

1 reference

Hog cholera: an update of present knowledge

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Identification of conserved epitopes on a hog cholera virus protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Development of a classical swine fever subunit marker vaccine and companion diagnostic test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Protection of pigs against ‘in contact’ challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

DNA-mediated protection against classical swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Immunogenicity of cholera toxin B epitope inserted in Salmonella flagellin expressed on bacteria and administered as DNA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Candidate peptide vaccine induced protection against classical swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Protection of cattle against foot-and-mouth disease by a synthetic peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

7 January 2021

inferred from DOI database lookup

Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

7 January 2021

inferred from DOI database lookup

Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.042

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2006.06.042

1 reference

20 September 2017

1 reference